<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="EN">
<head>
<meta name="viewport" content="width=840, height=1080"/>
<meta charset="utf-8"/>
<title>The Morphology of Human Blood Cells</title>
<link href="template.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<div>
<img class="stl_03" src="images/036.jpg" alt=""/>
<div class="layer">
<div class="stl_04 stl_05">
<div style="position:absolute; top:2.6736em; left:3.75em;"><span class="stl_521 stl_07 stl_42" style="word-spacing:0.0027em;">The Morphology of</span><span class="stl_521 stl_07 stl_42" style="word-spacing:0.0327em;"> Human</span><span class="stl_521 stl_07 stl_42" style="word-spacing:0.0028em;"> Blood</span><span class="stl_521 stl_07 stl_42" style="word-spacing:0.0028em;"> Cells &#160;</span></div>
<div style="position:absolute; top:6.6667em; left:6.75em;"><span class="stl_522 stl_07 stl_69" style="word-spacing:0.0504em;">breakpoint cluster region (bcr) of</span><span class="stl_522 stl_07 stl_69" style="word-spacing:0.0794em;"> chromosome</span><span class="stl_522 stl_07 stl_69" style="word-spacing:0.0504em;"> 22</span><span class="stl_522 stl_07 stl_69" style="word-spacing:0.0504em;"> creating &#160;</span></div>
<div style="position:absolute; top:6.5921em; left:28em;"><span class="stl_523 stl_89 stl_68" style="word-spacing:0.0282em;">Blast Crisis of CML &#160;</span></div>
<div style="position:absolute; top:7.6663em; left:6.75em;"><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2752em;">a chimeric bcr-abl gene.</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2452em;"> The</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2752em;"> complete function of</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.3052em;"> this &#160;</span></div>
<div style="position:absolute; top:8.6659em; left:6.75em;"><span class="stl_522 stl_07 stl_81" style="word-spacing:0.0498em;">chimeric gene is not well understood and it is thought that &#160;</span></div>
<div style="position:absolute; top:9.6655em; left:6.75em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:0.2561em;">the bcr-abl fusion gene generates a hyperactive tyrosine &#160;</span></div>
<div style="position:absolute; top:10.6651em; left:6.75em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0011em;">kinase that signals uncontrolled proliferation of</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0301em;"> the</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0011em;"> affected &#160;</span></div>
<div style="position:absolute; top:11.6647em; left:6.75em;"><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0148em;">cells. Because</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0448em;"> of</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0748em;"> the</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0448em;"> increased evidence linking CML to</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0448em;"> the &#160;</span></div>
<div style="position:absolute; top:12.6643em; left:6.75em;"><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2382em;">Ph chromosome,</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2082em;"> the</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2382em;"> disease is currently defined by</span><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2382em;"> the &#160;</span></div>
<div style="position:absolute; top:13.6639em; left:6.75em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0101em;">presence of</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0391em;"> cytogenetic</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0101em;"> translocation t(9,22) or by the</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0101em;"> pres- &#160;</span></div>
<div style="position:absolute; top:14.6635em; left:6.75em;"><span class="stl_522 stl_07 stl_60" style="word-spacing:0.1615em;">ence of</span><span class="stl_522 stl_07 stl_60" style="word-spacing:0.1915em;"> the</span><span class="stl_522 stl_07 stl_60" style="word-spacing:0.1615em;"> rearrangement bcr-abl on DNA analysis.</span><span class="stl_522 stl_07 stl_60" style="word-spacing:0.1315em;"> It</span><span class="stl_522 stl_07 stl_60" style="word-spacing:0.1615em;"> is &#160;</span></div>
<div style="position:absolute; top:15.6631em; left:6.75em;"><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0067em;">important to remember that the Ph chromosome is also the &#160;</span></div>
<div style="position:absolute; top:16.6627em; left:6.75em;"><span class="stl_522 stl_07 stl_524" style="word-spacing:0.3372em;">most common karyotypic abnormality found in adult &#160;</span></div>
<div style="position:absolute; top:17.6622em; left:6.75em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0672em;">patients with acute lymphoblastic leukemia.</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0372em;"> Progression</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0672em;"> of &#160;</span></div>
<div style="position:absolute; top:18.6618em; left:6.75em;"><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0335em;">CML to the blastic phase may be associated with the acqui- &#160;</span></div>
<div style="position:absolute; top:19.6614em; left:6.75em;"><span class="stl_522 stl_07 stl_40" style="word-spacing:0.0223em;">sition of</span><span class="stl_522 stl_07 stl_40" style="word-spacing:0.0513em;"> new</span><span class="stl_522 stl_07 stl_40" style="word-spacing:0.0223em;"> cytogenetic</span><span class="stl_522 stl_07 stl_40" style="word-spacing:0.0223em;"> anomalies. &#160;</span></div>
<div style="position:absolute; top:7.6834em; left:28em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:0.1031em;">CML is predestined to transform to acute or blastic phase &#160;</span></div>
<div style="position:absolute; top:8.683em; left:28em;"><span class="stl_522 stl_07 stl_115" style="word-spacing:0.1754em;">which may be preceded by an accelerated phase.</span><span class="stl_522 stl_07 stl_115" style="word-spacing:0.1454em;"> Patients &#160;</span></div>
<div style="position:absolute; top:9.6826em; left:28em;"><span class="stl_522 stl_07 stl_64" style="word-spacing:0.0741em;">with accelerated or blastic phase usually complain of</span><span class="stl_522 stl_07 stl_64" style="word-spacing:0.1031em;"> fever, &#160;</span></div>
<div style="position:absolute; top:10.6822em; left:28em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:0.014em;">sweats, weight</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.045em;"> loss,</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.014em;"> bone</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.045em;"> pain,</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.014em;"> and</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.045em;"> increasing tenderness</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.045em;"> at &#160;</span></div>
<div style="position:absolute; top:11.6818em; left:28em;"><span class="stl_522 stl_07 stl_24" style="word-spacing:0.2094em;">the splenic area.</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.1794em;"> The</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.2094em;"> average time for transformation</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.2094em;"> to &#160;</span></div>
<div style="position:absolute; top:12.6814em; left:28em;"><span class="stl_522 stl_07 stl_98" style="word-spacing:-0.0155em;">acute phase is 4 years; however, metamorphosis can occur as &#160;</span></div>
<div style="position:absolute; top:13.681em; left:28em;"><span class="stl_522 stl_07 stl_44" style="word-spacing:0.0592em;">early as 2 years and as late as 10 years after the initial diag- &#160;</span></div>
<div style="position:absolute; top:14.6806em; left:28em;"><span class="stl_522 stl_07 stl_160" style="word-spacing:0.0881em;">nosis. Observations</span><span class="stl_522 stl_07 stl_160" style="word-spacing:0.1191em;"> in the blood during blast</span><span class="stl_522 stl_07 stl_160" style="word-spacing:0.1191em;"> transforma- &#160;</span></div>
<div style="position:absolute; top:15.6802em; left:28em;"><span class="stl_522 stl_07 stl_16" style="word-spacing:0.1456em;">tion reveal excess blasts and promyelocytes that may out- &#160;</span></div>
<div style="position:absolute; top:16.6798em; left:28em;"><span class="stl_522 stl_07 stl_131" style="word-spacing:0.2014em;">number the myelocytes and metamyelocytes.</span><span class="stl_522 stl_07 stl_131" style="word-spacing:0.1714em;"> In</span><span class="stl_522 stl_07 stl_131" style="word-spacing:0.2014em;"> approxi- &#160;</span></div>
<div style="position:absolute; top:17.6794em; left:28em;"><span class="stl_522 stl_07 stl_40" style="word-spacing:-0.0123em;">mately 70% of CML patients the blastic transformation is of &#160;</span></div>
<div style="position:absolute; top:18.679em; left:28em;"><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0214em;">myeloid lineage while in 30% the predominantly malignant &#160;</span></div>
<div style="position:absolute; top:19.6786em; left:28em;"><span class="stl_522 stl_07 stl_197" style="word-spacing:0.0173em;">cell has lymphoblastic morphology (</span><span class="stl_525 stl_07 stl_224" style="word-spacing:0.0189em;">PLATE</span><span class="stl_522 stl_07 stl_197" style="word-spacing:0.0759em;"> 46). &#160;</span></div>
<div style="position:absolute; top:21.5754em; left:6.75em;"><span class="stl_523 stl_89 stl_68" style="word-spacing:0.0283em;">Clinical Description &#160;</span></div>
<div style="position:absolute; top:21.5921em; left:28em;"><span class="stl_523 stl_89 stl_360">Treatment &#160;</span></div>
<div style="position:absolute; top:22.6667em; left:6.75em;"><span class="stl_522 stl_07 stl_76" style="word-spacing:0.3338em;">The annual incidence of</span><span class="stl_522 stl_07 stl_76" style="word-spacing:0.3386em;"> CML in the United States</span><span class="stl_522 stl_07 stl_76" style="word-spacing:0.3386em;"> is &#160;</span></div>
<div style="position:absolute; top:23.6663em; left:6.75em;"><span class="stl_522 stl_07 stl_64" style="word-spacing:0.2343em;">approximately 4,000 new cases which account for about &#160;</span></div>
<div style="position:absolute; top:22.6834em; left:28em;"><span class="stl_522 stl_07 stl_34" style="word-spacing:0.0486em;">The initial goal of</span><span class="stl_522 stl_07 stl_34" style="word-spacing:0.0786em;"> treatment</span><span class="stl_522 stl_07 stl_34" style="word-spacing:0.0487em;"> should aim at relieving</span><span class="stl_522 stl_07 stl_34" style="word-spacing:0.0487em;"> symp- &#160;</span></div>
<div style="position:absolute; top:23.683em; left:28em;"><span class="stl_522 stl_07 stl_68" style="word-spacing:0.1929em;">toms and controlling the high cell count.</span><span class="stl_522 stl_07 stl_68" style="word-spacing:0.1629em;"> This</span><span class="stl_522 stl_07 stl_68" style="word-spacing:0.1929em;"> is</span><span class="stl_522 stl_07 stl_68" style="word-spacing:0.1929em;"> usually &#160;</span></div>
<div style="position:absolute; top:24.6826em; left:28em;"><span class="stl_522 stl_07 stl_125" style="word-spacing:0.1521em;">achieved by using hydroxyurea,</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.1231em;"> a</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.1521em;"> drug that inhibits</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.1521em;"> DNA &#160;</span></div>
<div style="position:absolute; top:25.5239em; left:28em;"><span class="stl_522 stl_07 stl_41" style="word-spacing:-0.0151em;">synthesis. Combination</span><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0149em;"> of</span><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0439em;"> interferon-</span><span class="stl_485 stl_148 stl_41" style="word-spacing:0.0439em;">α</span><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0439em;">,</span><span class="stl_522 stl_07 stl_41" style="word-spacing:-0.0151em;"> a</span><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0149em;"> biologic</span><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0149em;"> response &#160;</span></div>
<div style="position:absolute; top:26.6818em; left:28.0008em;"><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0746em;">modifier, and</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.1056em;"> cytosine-arabinoside are considered the</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.1056em;"> best &#160;</span></div>
<div style="position:absolute; top:27.6814em; left:28.0008em;"><span class="stl_522 stl_07 stl_75" style="word-spacing:0.2418em;">treatment available for management of</span><span class="stl_522 stl_07 stl_75" style="word-spacing:0.2728em;"> CML.</span><span class="stl_522 stl_07 stl_75" style="word-spacing:0.2128em;"> Treatment &#160;</span></div>
<div style="position:absolute; top:28.681em; left:28.0008em;"><span class="stl_522 stl_07 stl_80" style="word-spacing:-0.0191em;">with this combination yields better results than hydroxyurea &#160;</span></div>
<div style="position:absolute; top:29.6806em; left:28.0008em;"><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0713em;">and may prolong survival of</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.1013em;"> patients</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0713em;"> in the chronic</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0713em;"> phase. &#160;</span></div>
<div style="position:absolute; top:30.5219em; left:28.0008em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0278em;">Interferon-</span><span class="stl_485 stl_148 stl_21" style="word-spacing:0.0278em;">α </span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0278em;">alone</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0911em;"> or in combination with</span><span class="stl_522 stl_07 stl_21" style="word-spacing:0.0911em;"> cytosine-arabi- &#160;</span></div>
<div style="position:absolute; top:31.6798em; left:28.0008em;"><span class="stl_522 stl_07 stl_15" style="word-spacing:0.0637em;">noside may also lead to clonal remission (normalization of &#160;</span></div>
<div style="position:absolute; top:32.6794em; left:28.0008em;"><span class="stl_522 stl_07 stl_41" style="word-spacing:-0.0281em;">the cytogenetic defect) in approximately 20-30% of patients. &#160;</span></div>
<div style="position:absolute; top:33.679em; left:28.0008em;"><span class="stl_522 stl_07 stl_138" style="word-spacing:0.1069em;">Although chemotherapy can improve the quality of</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.1369em;"> life,</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0769em;"> it &#160;</span></div>
<div style="position:absolute; top:34.6786em; left:28.0008em;"><span class="stl_522 stl_07 stl_138" style="word-spacing:0.2348em;">does not cure the disease.</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.2048em;"> Bone</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.2348em;"> marrow</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.2348em;"> transplantation &#160;</span></div>
<div style="position:absolute; top:35.6782em; left:28.0008em;"><span class="stl_522 stl_07 stl_131" style="word-spacing:-0.0236em;">from an HLA-match sibling provides the only curative treat- &#160;</span></div>
<div style="position:absolute; top:36.6778em; left:28.0008em;"><span class="stl_522 stl_07 stl_526" style="word-spacing:0.3657em;">ment for CML.</span><span class="stl_522 stl_07 stl_526" style="word-spacing:0.3597em;"> Recently a tyrosine kinase</span><span class="stl_522 stl_07 stl_526" style="word-spacing:0.3597em;"> inhibitor &#160;</span></div>
<div style="position:absolute; top:24.6659em; left:6.75em;"><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0848em;">20% of</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.1148em;"> all</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0848em;"> leukemias.</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0548em;"> The</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.0848em;"> median age at the time of</span><span class="stl_522 stl_07 stl_138" style="word-spacing:0.1148em;"> diag- &#160;</span></div>
<div style="position:absolute; top:25.6655em; left:6.75em;"><span class="stl_522 stl_07 stl_242" style="word-spacing:-0.0142em;">nosis is 60 years. However, recently, an increasing number of &#160;</span></div>
<div style="position:absolute; top:26.6651em; left:6.75em;"><span class="stl_522 stl_07 stl_41" style="word-spacing:0.0758em;">young patients have been diagnosed in our institution and &#160;</span></div>
<div style="position:absolute; top:27.6647em; left:6.75em;"><span class="stl_522 stl_07 stl_77" style="word-spacing:0.0297em;">other centers in the United States. &#160;</span></div>
<div style="position:absolute; top:28.6643em; left:8.2502em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:-0.0453em;">In the chronic phase, patients with CML may be asymp- &#160;</span></div>
<div style="position:absolute; top:29.6639em; left:6.75em;"><span class="stl_522 stl_07 stl_81" style="word-spacing:0.0197em;">tomatic presenting only with an elevated granulocyte count &#160;</span></div>
<div style="position:absolute; top:30.6635em; left:6.75em;"><span class="stl_522 stl_07 stl_111" style="word-spacing:0.1046em;">discovered on routine laboratory tests.</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0746em;"> Patients</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.1046em;"> with</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.1046em;"> white &#160;</span></div>
<div style="position:absolute; top:31.6631em; left:6.75em;"><span class="stl_522 stl_07 stl_138" style="word-spacing:0.1657em;">cell count (WBC) above 30,000 usually report symptoms &#160;</span></div>
<div style="position:absolute; top:32.6627em; left:6.75em;"><span class="stl_522 stl_07 stl_18" style="word-spacing:0.181em;">such as fatigue,</span><span class="stl_522 stl_07 stl_18" style="word-spacing:0.15em;"> malaise, and</span><span class="stl_522 stl_07 stl_18" style="word-spacing:0.181em;"> low grade fever.</span><span class="stl_522 stl_07 stl_18" style="word-spacing:0.131em;"> With</span><span class="stl_522 stl_07 stl_18" style="word-spacing:0.161em;"> WBC &#160;</span></div>
<div style="position:absolute; top:33.6623em; left:6.75em;"><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0305em;">exceeding 80,000,</span><span class="stl_522 stl_07 stl_111" style="word-spacing:-0.0005em;"> patients</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0305em;"> may complain of</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0595em;"> abdominal</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0305em;"> dis- &#160;</span></div>
<div style="position:absolute; top:34.6619em; left:6.75em;"><span class="stl_522 stl_07 stl_103" style="word-spacing:0.2214em;">tention or discomfort secondary to an enlarged spleen. &#160;</span></div>
<div style="position:absolute; top:35.6615em; left:6.75em;"><span class="stl_522 stl_07 stl_47" style="word-spacing:-0.008em;">Weight loss and bone pain may be prominent complaints by &#160;</span></div>
<div style="position:absolute; top:36.6611em; left:6.75em;"><span class="stl_522 stl_07 stl_59" style="word-spacing:-0.0571em;">some patients, especially with very high WBC. Splenomegaly &#160;</span></div>
<div style="position:absolute; top:37.6607em; left:6.75em;"><span class="stl_522 stl_07 stl_127" style="word-spacing:-0.0789em;">is possibly the most common physical finding,being detected &#160;</span></div>
<div style="position:absolute; top:38.6603em; left:6.75em;"><span class="stl_522 stl_07 " style="word-spacing:-0.0917em;">in more than 90% of patients. The liver is palpable in approx- &#160;</span></div>
<div style="position:absolute; top:39.6599em; left:6.75em;"><span class="stl_522 stl_07 stl_44" style="word-spacing:-0.0627em;">imately 50% of patients in the chronic phase. &#160;</span></div>
<div style="position:absolute; top:37.7113em; left:30.7879em;"><span class="stl_527 stl_07 stl_73">®</span></div>
<div style="position:absolute; top:37.6774em; left:28.0008em;"><span class="stl_522 stl_07 stl_133" style="word-spacing:0.0522em;">(Gleevec )</span><span class="stl_522 stl_07 stl_133" style="word-spacing:0.189em;"> has been approved and is considered now</span><span class="stl_522 stl_07 stl_133" style="word-spacing:0.189em;"> the &#160;</span></div>
<div style="position:absolute; top:38.683em; left:28.0002em;"><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0052em;">first line of</span><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0342em;"> treatment</span><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0053em;"> in the majority of</span><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0343em;"> patients</span><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0052em;"> with</span><span class="stl_522 stl_07 stl_59" style="word-spacing:0.0052em;"> CML. &#160;</span></div>
<div style="position:absolute; top:40.7439em; left:28em;"><span class="stl_528 stl_171 stl_529" style="word-spacing:0.0046em;">Polycythemia Vera &#160;</span></div>
<div style="position:absolute; top:41.5754em; left:6.75em;"><span class="stl_523 stl_89 stl_41" style="word-spacing:0.0279em;">Hematology Findings &#160;</span></div>
<div style="position:absolute; top:42.5167em; left:28em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0233em;">Polycythemia vera (PV) is a clonal hematologic malignancy &#160;</span></div>
<div style="position:absolute; top:43.5163em; left:28em;"><span class="stl_522 stl_07 stl_68" style="word-spacing:0.031em;">characterized by increased proliferation of</span><span class="stl_522 stl_07 stl_68" style="word-spacing:0.061em;"> all</span><span class="stl_522 stl_07 stl_68" style="word-spacing:0.031em;"> hematopoiet- &#160;</span></div>
<div style="position:absolute; top:44.5159em; left:28em;"><span class="stl_522 stl_07 stl_67" style="word-spacing:-0.0001em;">ic elements within the bone marrow. As</span><span class="stl_522 stl_07 stl_67" style="word-spacing:0.0082em;"> in the case of</span><span class="stl_522 stl_07 stl_67" style="word-spacing:0.0372em;"> CML, &#160;</span></div>
<div style="position:absolute; top:45.5155em; left:28em;"><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0046em;">the clinical course of</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0336em;"> PV</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0046em;"> evolves gradually over several</span><span class="stl_522 stl_07 stl_111" style="word-spacing:0.0046em;"> years &#160;</span></div>
<div style="position:absolute; top:46.5151em; left:28em;"><span class="stl_522 stl_07 stl_42" style="word-spacing:0.0978em;">and many patients are expected to have normal survival if &#160;</span></div>
<div style="position:absolute; top:47.5147em; left:28em;"><span class="stl_522 stl_07 stl_131" style="word-spacing:-0.0036em;">appropriate measures are taken to control the production of &#160;</span></div>
<div style="position:absolute; top:48.5143em; left:28em;"><span class="stl_522 stl_07 stl_21" style="word-spacing:-0.0242em;">their red cell mass. Several factors including radiation, occu- &#160;</span></div>
<div style="position:absolute; top:49.5139em; left:28em;"><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0325em;">pational exposures,</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0025em;"> and</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0325em;"> hereditary defects have been</span><span class="stl_522 stl_07 stl_24" style="word-spacing:0.0325em;"> impli- &#160;</span></div>
<div style="position:absolute; top:50.5135em; left:28em;"><span class="stl_522 stl_07 stl_473" style="word-spacing:0.0352em;">cated in the pathogenesis of</span><span class="stl_522 stl_07 stl_473" style="word-spacing:0.0642em;"> PV. &#160;</span></div>
<div style="position:absolute; top:42.6667em; left:6.75em;"><span class="stl_522 stl_07 " style="word-spacing:-0.0472em; letter-spacing:-2px;">Hematologic findings of CML include a neutrophilic leukocy-</span></div>
<div style="position:absolute; top:43.6663em; left:6.75em;"><span class="stl_522 stl_07 stl_78" style="word-spacing:0.0505em;">tosis (20 to 500x10</span><span class="stl_522 stl_07 stl_78" style="word-spacing:0.1585em;"> /l)</span><span class="stl_522 stl_07 stl_78" style="word-spacing:0.0505em;"> with all stages of</span><span class="stl_522 stl_07 stl_78" style="word-spacing:0.0795em;"> neutrophil</span><span class="stl_522 stl_07 stl_78" style="word-spacing:0.0505em;"> matura- &#160;</span></div>
<div style="position:absolute; top:44.6663em; left:6.75em;"><span class="stl_522 stl_07 stl_157" style="word-spacing:0.0843em;">tion: myeloblast</span><span class="stl_522 stl_07 stl_157" style="word-spacing:0.0943em;"> (<span class="stl_439">±</span>3%);</span><span class="stl_522 stl_07 stl_157" style="word-spacing:0.0843em;"> progranulocyte</span><span class="stl_522 stl_07 stl_157" style="word-spacing:0.0943em;"> (<span class="stl_439">±</span>4%);</span><span class="stl_522 stl_07 stl_157" style="word-spacing:0.0843em;"> myelocyte, &#160;</span></div>
<div style="position:absolute; top:45.6659em; left:6.75em;"><span class="stl_522 stl_07 stl_98" style="word-spacing:-0.0152em;">metamyelocyte, band</span><span class="stl_522 stl_07 stl_98" style="word-spacing:-0.0002em;"> (<span class="stl_439">±</span>40%), segmented</span><span class="stl_522 stl_07 stl_98" style="word-spacing:0.0148em;"> (<span class="stl_439">±</span></span><span class="stl_522 stl_07 stl_98" style="word-spacing:0.1448em;"> 35%)</span><span class="stl_522 stl_07 stl_98" style="word-spacing:0.1448em;"> (</span><span class="stl_525 stl_07 stl_23" style="word-spacing:0.0162em;">PLATES &#160;</span></div>
<div style="position:absolute; top:43.563em; left:12.8571em;"><span class="stl_530 stl_07 stl_73">9</span></div>
<div style="position:absolute; top:46.6667em; left:6.75em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:-0.0346em;">45, 46).An absolute basophilia is an important blood finding &#160;</span></div>
<div style="position:absolute; top:47.6663em; left:6.75em;"><span class="stl_522 stl_07 stl_25" style="word-spacing:0.006em;">and often precedes clinical manifestations. Eosinophilia may &#160;</span></div>
<div style="position:absolute; top:48.6659em; left:6.75em;"><span class="stl_522 stl_07 stl_531" style="word-spacing:0.063em;">be noted.</span><span class="stl_522 stl_07 stl_531" style="word-spacing:0.034em;"> Occasional</span><span class="stl_522 stl_07 stl_531" style="word-spacing:0.063em;"> monocytes may be present.</span><span class="stl_522 stl_07 stl_531" style="word-spacing:0.034em;"> Leukocyte &#160;</span></div>
<div style="position:absolute; top:49.6655em; left:6.75em;"><span class="stl_522 stl_07 stl_55" style="word-spacing:-0.0353em;">alkaline phosphatase stain of mature neutrophils is decreased &#160;</span></div>
<div style="position:absolute; top:50.6651em; left:6.75em;"><span class="stl_522 stl_07 stl_220" style="word-spacing:-0.0641em;">in CML (</span><span class="stl_525 stl_07 stl_135" style="word-spacing:-0.07em;">PLATES </span><span class="stl_522 stl_07 stl_220" style="word-spacing:-0.1141em;">46, 48, Part 2). Thrombocytosis is present in &#160;</span></div>
<div style="position:absolute; top:51.6663em; left:6.7501em;"><span class="stl_522 stl_07 stl_158" style="word-spacing:-0.0012em;">about half</span><span class="stl_522 stl_07 stl_158" style="word-spacing:0.0278em;"> of the</span><span class="stl_522 stl_07 stl_158" style="word-spacing:-0.007em;"> cases; the platelets may be large.</span><span class="stl_522 stl_07 stl_158" style="word-spacing:-0.007em;"> Occasional &#160;</span></div>
<div style="position:absolute; top:52.6659em; left:6.7501em;"><span class="stl_522 stl_07 stl_125" style="word-spacing:0.0719em;">megakaryocyte fragments may be observed.</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.0419em;"> There</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.0719em;"> is a</span><span class="stl_522 stl_07 stl_125" style="word-spacing:0.0719em;"> nor- &#160;</span></div>
<div style="position:absolute; top:53.6655em; left:6.7501em;"><span class="stl_522 stl_07 stl_193" style="word-spacing:-0.0402em;">mocytic normochromic anemia at diagnosis. Minimal aniso- &#160;</span></div>
<div style="position:absolute; top:54.6651em; left:6.7501em;"><span class="stl_522 stl_07 stl_193" style="word-spacing:0.0186em;">cytosis and poikilocytosis with an occasional nucleated RBC &#160;</span></div>
<div style="position:absolute; top:55.6647em; left:6.7501em;"><span class="stl_522 stl_07 " style="word-spacing:-0.0286em; letter-spacing:-2px;">are frequently observed. The bone marrow is markedly hyper-</span></div>
<div style="position:absolute; top:56.6643em; left:6.7501em;"><span class="stl_522 stl_07 stl_531" style="word-spacing:-0.008em;">cellular with neutrophilic precursors from myeloblast to seg- &#160;</span></div>
<div style="position:absolute; top:57.6639em; left:6.7501em;"><span class="stl_522 stl_07 stl_122" style="word-spacing:0.2283em;">mented neutrophil.</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.1983em;"> Usually</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.2283em;"> there are no more than</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.2283em;"> 5% &#160;</span></div>
<div style="position:absolute; top:58.6635em; left:6.7501em;"><span class="stl_522 stl_07 stl_531" style="word-spacing:0.0889em;">myeloblasts. Basophils</span><span class="stl_522 stl_07 stl_531" style="word-spacing:0.1199em;"> and eosinophils are often</span><span class="stl_522 stl_07 stl_531" style="word-spacing:0.1199em;"> increased. &#160;</span></div>
<div style="position:absolute; top:59.6631em; left:6.7501em;"><span class="stl_522 stl_07 stl_257" style="word-spacing:0.0603em;">Megakaryocytes may be increased.</span><span class="stl_522 stl_07 stl_257" style="word-spacing:0.0303em;"> Erythroid</span><span class="stl_522 stl_07 stl_257" style="word-spacing:0.0603em;"> precursors</span><span class="stl_522 stl_07 stl_257" style="word-spacing:0.0603em;"> are &#160;</span></div>
<div style="position:absolute; top:60.6627em; left:6.7501em;"><span class="stl_522 stl_07 stl_533" style="word-spacing:-0.016em;">found in normal, increased, or decreased numbers. Myeloid- &#160;</span></div>
<div style="position:absolute; top:61.6623em; left:6.7501em;"><span class="stl_522 stl_07 stl_98" style="word-spacing:-0.0713em;">erythroid ratio is increased. &#160;</span></div>
<div style="position:absolute; top:52.4255em; left:28em;"><span class="stl_523 stl_89 stl_68" style="word-spacing:0.0284em;">Clinical Features &#160;</span></div>
<div style="position:absolute; top:53.5167em; left:28em;"><span class="stl_522 stl_07 stl_16" style="word-spacing:0.0676em;">The clinical features of</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.0966em;"> PV</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.0676em;"> are the direct result of</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.0966em;"> excessive &#160;</span></div>
<div style="position:absolute; top:54.5163em; left:28em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:-0.0057em;">production of</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0233em;"> blood</span><span class="stl_522 stl_07 stl_61" style="word-spacing:-0.01em;"> cells. The diagnosis may be an</span><span class="stl_522 stl_07 stl_61" style="word-spacing:-0.01em;"> inciden- &#160;</span></div>
<div style="position:absolute; top:55.5159em; left:28em;"><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0573em;">tal finding of</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0872em;"> increased</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0572em;"> red blood cells in an</span><span class="stl_522 stl_07 stl_61" style="word-spacing:0.0572em;"> asymptomatic &#160;</span></div>
<div style="position:absolute; top:56.5155em; left:28em;"><span class="stl_522 stl_07 stl_35" style="word-spacing:0.1315em;">patient on a routine office visit.</span><span class="stl_522 stl_07 stl_35" style="word-spacing:0.1015em;"> Excessive</span><span class="stl_522 stl_07 stl_35" style="word-spacing:0.1315em;"> increase in</span><span class="stl_522 stl_07 stl_35" style="word-spacing:0.1315em;"> ery- &#160;</span></div>
<div style="position:absolute; top:57.5151em; left:28em;"><span class="stl_522 stl_07 stl_44" style="word-spacing:0.2832em;">throcyte count may cause symptoms such as headache, &#160;</span></div>
<div style="position:absolute; top:58.5147em; left:28em;"><span class="stl_522 stl_07 stl_122" style="word-spacing:0.0823em;">dizziness, blurred</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.1113em;"> vision,</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.0823em;"> and</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.1113em;"> puritis.</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.0823em;"> These</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.1113em;"> symptoms</span><span class="stl_522 stl_07 stl_122" style="word-spacing:0.1113em;"> are &#160;</span></div>
<div style="position:absolute; top:59.5143em; left:28em;"><span class="stl_522 stl_07 stl_15" style="word-spacing:0.1317em;">referred to as hyperviscosity syndrome.</span><span class="stl_522 stl_07 stl_15" style="word-spacing:0.1017em;"> Physical</span><span class="stl_522 stl_07 stl_15" style="word-spacing:0.1317em;"> examina- &#160;</span></div>
<div style="position:absolute; top:60.5139em; left:28em;"><span class="stl_522 stl_07 stl_131" style="word-spacing:0.2615em;">tion usually reveals conjunctival plethora,</span><span class="stl_522 stl_07 stl_131" style="word-spacing:0.2315em;"> hepatomegaly, &#160;</span></div>
<div style="position:absolute; top:61.5135em; left:28em;"><span class="stl_522 stl_07 stl_16" style="word-spacing:0.1996em;">and splenomegaly.</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.1696em;"> Thrombosis</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.1996em;"> is a common problem</span><span class="stl_522 stl_07 stl_16" style="word-spacing:0.1996em;"> in &#160;</span></div>
<div style="position:absolute; top:64.0452em; left:3.75em;"><span class="stl_534 stl_89 stl_90">28 &#160;</span></div>
</div>
</div>
</div>
</body>
</html>
